Results from a UK-based prospective cohort study.

Clinicians advised vigilance for liver injury and herpes meningoencephalitis.

In a 10-year study, fewer than 1 in 5 patients received an antiepileptic class agent.

Older age, prior C diff infection events are factors in treatment failure.

Findings from the largest ever study of device-measured physical activity and cardiovascular disease highlight protective benefits of exercise.

Post-anthracycline statin exposure is linked to reduced HF hospitalization.

The ACTIV-2 trial will initially enrol 220 participants with mild or moderate COVID-19 who are at risk for disease progression.

The latest stories you need to know.

COVID-19 Around the world weekly highlights: Israel leading the vaccination race, new virus variants...

Results from a multicentre, randomised, placebo-controlled trial.

Findings from a cross-sectional analysis.

Even virtual interactions might reduce risk.

Early treatment cuts risk by 48% in older patients with mild disease.

Meta-analysis also shows no differences for stroke.